Design, Synthesis and Biological Evaluation of Arylpyridin-2-yl Guanidine Derivatives and Cyclic Mimetics as Novel MSK1 Inhibitors. An Application in an Asthma Model.

MLA

Bollenbach, Maud, et al. “Design, Synthesis and Biological Evaluation of Arylpyridin-2-Yl Guanidine Derivatives and Cyclic Mimetics as Novel MSK1 Inhibitors. An Application in an Asthma Model.” Molecules, vol. 26, no. 2, Jan. 2021, p. 391. EBSCOhost, https://doi.org/10.3390/molecules26020391.

APA

Bollenbach, M., Nemska, S., Wagner, P., Camelin, G., Daubeuf, F., Obrecht, A., Villa, P., Rognan, D., Bihel, F., Bourguignon, J.-J., Schmitt, M., Frossard, N., & Marchand, P. (2021). Design, Synthesis and Biological Evaluation of Arylpyridin-2-yl Guanidine Derivatives and Cyclic Mimetics as Novel MSK1 Inhibitors. An Application in an Asthma Model. Molecules, 26(2), 391. https://doi.org/10.3390/molecules26020391

Chicago

Bollenbach, Maud, Simona Nemska, Patrick Wagner, Guillaume Camelin, François Daubeuf, Adeline Obrecht, Pascal Villa, et al. 2021. “Design, Synthesis and Biological Evaluation of Arylpyridin-2-Yl Guanidine Derivatives and Cyclic Mimetics as Novel MSK1 Inhibitors. An Application in an Asthma Model.” Molecules 26 (2): 391. doi:10.3390/molecules26020391.